Your browser doesn't support javascript.
loading
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
Brewer, Raymond; Blum, Kenneth; Bowirrat, Abdalla; Modestino, Edward J; Baron, David; Badgaiyan, Rajendra D; Moran, Mark; Boyett, Brent; Gold, Mark S.
Afiliação
  • Brewer R; Department of Nutrigenomics, Genomic Testing Center, Geneus Health, LLC., San Antonio, TX, USA.
  • Blum K; Department of Nutrigenomics, Genomic Testing Center, Geneus Health, LLC., San Antonio, TX, USA.
  • Bowirrat A; Western University Health Sciences, Pomona, CA., USA.
  • Modestino EJ; Division of Neuroscience and Addiction Research, Pathway Healthcare, Birmingham, AL, USA.
  • Baron D; Eotvos Loránd University, Institute of Psychology, Budapest, Hungary.
  • Badgaiyan RD; Department of Psychiatry, Wright State University Boonshoft School of Medicine and Dayton VA Medical Center, Dayton, OH, USA.
  • Moran M; Department of Psychiatry, University of Vermont, Burlington, VT., USA.
  • Boyett B; Department of Neuroscience and Genetics, Interdisciplinary Center Herzliya, Israel.
  • Gold MS; Department of Psychology, Curry College, Milton, MA., USA.
Curr Psychopharmacol ; 9(3): 164-184, 2020.
Article em En | MEDLINE | ID: mdl-37361136

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Psychopharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Psychopharmacol Ano de publicação: 2020 Tipo de documento: Article